Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K043442
    Date Cleared
    2005-05-31

    (168 days)

    Product Code
    Regulation Number
    882.4725
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    STRYKER RF COAXIAL BIPOLAR ELECTRODES & CANNULAE

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Stryker RF Coaxial Bipolar Electrodes and Cannulae, in combination with the Stryker RF Generator, are intended for coagulation of soft tissues in orthopedic, spinal, and neurosurgical applications. They are also used for selective denervation and tissue destruction procedures which may be performed on the lumbar, thoracic, and cervical regions of the spinal cord, peripheral nerves, and nerve roots for the relief of pain. Examples include, but are not limited to, Facette Denervation, Percutaneous Chordotomy/Dorsal Root Entry Zone (DREZ) Lesion, Trigeminus Neuralgia, Peripheral Neuralgia and Rhizotomy.

    Device Description

    The Stryker RF Coaxial Bipolar Electrodes and Cannulae will be used in conjunction with the Stryker RF Generator and Connector Cable to create radiofrequency lesions in nerve tissue. The generator applies temperature-controlled, radio frequency (RF) energy into targeted nerve tissue via an electrode probe. This energy destroys the nerve tissue's ability to conduct electrical signals. Pain relief is achieved by creating defined lesions on pain-conducting nerve fibers or tissue.

    The two poles of the bipolar circuit will be referred to as RF1 and RF2. RF1 will define the sending pole while RF2 will define the return pole. Cannulae have both RF1 and RF2 Electrode connections. A secondary conductive surface (RF2) is offset axially to RF1 providing the return path for the RF energy. Thus the RF energy travels from the RF1 pole to the RF2 pole on the same probe. A lesion will be created between RF1 and RF2 on the singular probe.

    AI/ML Overview

    This document is a 510(k) summary for the Stryker RF Coaxial Bipolar Electrodes and Cannulae. It states that the device is substantially equivalent to existing predicate devices. Therefore, the information typically found in a study demonstrating the device meets acceptance criteria (like specific performance metrics, sample sizes, expert qualifications, and study designs) is not present in this document.

    The core argument for acceptance is substantial equivalence rather than direct performance testing against new acceptance criteria.

    Here's how the requested information would apply to this document:

    1. A table of acceptance criteria and the reported device performance

    This document does not provide a table of acceptance criteria and reported device performance because the device's acceptance is based on substantial equivalence to predicate devices, not on meeting new, specific performance metrics. The implicit "acceptance criteria" is that the device is as safe and effective as the predicate devices.

    Acceptance CriteriaReported Device Performance
    No new safety concerns compared to predicate devicesThe document states: "The Stryker RF Coaxial Bipolar Electrodes and Cannulae do not raise any new safety and efficacy concerns when compared to similar devices already legally marketed."
    Equivalent effectiveness to predicate devicesThe document states: "The Stryker RF Coaxial Bipolar Electrodes and Cannulae are equivalent in intended use, safety, and effectiveness to existing devices being marketed by Stryker, Smith and Nephew and Baylis."

    2. Sample size used for the test set and the data provenance

    Not applicable. No new test set data is presented for this 510(k) submission. The substantial equivalence argument relies on the established safety and effectiveness of the predicate devices.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    Not applicable. No new test set data where experts would establish ground truth is presented.

    4. Adjudication method for the test set

    Not applicable. No new test set data is presented.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This device is an electrosurgical electrode and cannulae, not an AI-assisted diagnostic or therapeutic tool with human readers.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This device is not an algorithm, but a physical medical device.

    7. The type of ground truth used

    Not applicable in the context of new performance data. The "ground truth" for the substantial equivalence argument is the existing regulatory approval and demonstrated safety/effectiveness of the predicate devices.

    8. The sample size for the training set

    Not applicable. No training set for an algorithm is mentioned as this device is not an AI/ML product.

    9. How the ground truth for the training set was established

    Not applicable.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1